Patents by Inventor Patrick Harriott

Patrick Harriott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide fragments of murine epidermal growth factor as laminin receptor targets
    Patent number: 6995136
    Abstract: A peptide factor, its analogs and methods of using such peptide factor derived from murine epidermal growth factor peptide is disclosed wherein the peptide factor is modified to protect it from proteolytic degradation and the peptide binds to laminin receptors.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: February 7, 2006
    Assignee: The Queen's University of Belfast
    Inventors: John Nelson, Brian Walker, Neil McFerran, Patrick Harriott
  • Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
    Publication number: 20050272652
    Abstract: The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
    Type: Application
    Filed: March 25, 2005
    Publication date: December 8, 2005
    Inventors: Victor Gault, Finbarr O'Harte, Nigel Irwin, Patrick Harriott, Peter Flatt